NYSE:CVD - Covance Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$107.07 0.00 (0.00 %)
(As of 07/17/2018 07:46 AM ET)
Previous Close$107.07
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market Capitalization$6.06 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Covance logoCovance Inc. is engaged in drug development services. The Company provides a range of early-stage and late-stage product development services to the pharmaceutical and biotechnology industries. The Company also provides laboratory testing services to the chemical, agrochemical and food industries. The Company operates in two segments: early development services, and late-stage development services. The early development services include lead optimization services, preclinical services and clinical pharmacology services. The late-stage development services include central laboratory, Phase II-IV clinical development, and market access services.

Receive CVD News and Ratings via Email

Sign-up to receive the latest news and ratings for CVD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry N/A
Sub-IndustryLife Sciences Tools & Services
SectorN/A
SymbolNYSE:CVD
CUSIP22281610
Phone+1-609-4524440

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins7.70%
Return on Equity12.64%
Return on Assets8.17%

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market Cap$6,060.00

The Truth About Cryptocurrencies

Covance (NYSE:CVD) Frequently Asked Questions

What is Covance's stock symbol?

Covance trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVD."

How were Covance's earnings last quarter?

Covance Inc. (NYSE:CVD) released its earnings results on Wednesday, February, 4th. The healthcare company reported $0.97 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.97. The healthcare company had revenue of $634 million for the quarter, compared to analyst estimates of $631.30 million. Covance had a return on equity of 12.64% and a net margin of 7.70%. View Covance's Earnings History.

What is the consensus analysts' recommendation for Covance?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Covance in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Has Covance been receiving favorable news coverage?

News headlines about CVD stock have trended somewhat positive this week, according to Accern Sentiment. Accern scores the sentiment of news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Covance earned a daily sentiment score of 0.17 on Accern's scale. They also assigned news stories about the healthcare company an impact score of 46.50 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near term.

How do I buy shares of Covance?

Shares of CVD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Covance's stock price today?

One share of CVD stock can currently be purchased for approximately $107.07.

How big of a company is Covance?

Covance has a market capitalization of $6.06 billion.

How can I contact Covance?

Covance's mailing address is 210 Carnegie Ctr, PRINCETON, NJ 08540-6233, United States. The healthcare company can be reached via phone at +1-609-4524440.


MarketBeat Community Rating for Covance (NYSE CVD)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  172 (Vote Outperform)
Underperform Votes:  205 (Vote Underperform)
Total Votes:  377
MarketBeat's community ratings are surveys of what our community members think about Covance and other stocks. Vote "Outperform" if you believe CVD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.